> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Renews 5-Year M-CERSI Agreement
- URL: https://www.fdaweb.com/fda-renews-5-year-m-cersi-agreement/
- Published: 2023-08-30T12:00:00.000Z
- Updated: 2026-09-14T18:53:38.000Z
- Author: David McFarland
- Tags: Biologics, Drugs, Devices, #legacy-id-D5155215

FDA has renewed its funding for the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) under a new five-year $50 million cooperative agreement. A university [statement](https://www.umaryland.edu/news/archived-news/august-2023/fda-agreement-provides-50-million-for-regulatory-science-.php?ref=fdaweb.com) says M-CERSI is a partnership between two University of Maryland campuses and is the oldest of the five FDA-funded CERSIs in the country, having been started in 2011.

Since its 2018 funding renewal, M-CERSI says, it has continued its mission of modernizing and improving how drugs, biologics, and medical devices are reviewed and evaluated. “It has supported research projects and hosted conferences and workshops on topics related to its priority areas,” the statement says.

M-CERSI is currently collaborating with the agency on about 30 research projects across several FDA Centers, it says.